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spite this ongoing contact of the esophageal tissue with 
potential noxious agents, under normal circumstances no 
damage of the epithelium occurs. In this context, the 
main underlying protective factors of esophageal defens-
es are (1) luminal acid clearance and (2) esophageal epi-
thelial resistance  [2] .
 Luminal acid clearance is achieved by swallow-initiat-
ed peristalsis, gravity, and saliva  [3] . Saliva includes, 
among others, bicarbonate, which negates the effect of 
acid reflux  [4] . Nevertheless, luminal acid clearance is de-
layed and dependent on the time of day, as the beneficial 
effect of gravity, when in the upright posture, is limited 
during sleep  [5] .
 Since the esophageal epithelium is constantly impact-
ed by noxious agents, esophageal epithelial resistance 
plays a crucial role in protection ( table 1 ). In this review 
we will focus on the components of tissue resistance and 
will describe the mechanisms of action of the epithelium 
against injury.
 First Line of Defense – The Mucus Layer
 The first epithelial barrier against noxious material is 
the mucus layer, which can directly neutralize acid in the 
esophagus and protects by inhibiting contact of luminal 
agents to the esophageal squamous epithelium  [6] . It is 
known that expression of mucins changes within the dif-
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 Abstract
 Besides its important role of digestion and absorption, 
esophageal tissue has an essential role as a major barrier 
against intraluminal pathogens like hostile microorganisms 
and toxins. This barrier function is achieved via various me-
chanical, chemical, and immunological mechanisms which 
are typically altered in inflammatory diseases, thereby caus-
ing subsequent damage of the mucosa. In this review we will 
focus on the main structural and functional barriers of host 
defense within the esophageal mucosa, including the epi-
thelial layer, membrane-bound and secretory mucins, and 
different types of defensins. In addition, we will discuss the 
relevance of biofilm on esophageal tissue and will illustrate 
the importance of different regulators of intestinal perme-
ability like zonulin and desmosomal components.
 © 2014 S. Karger AG, Basel
 Introduction
 The esophageal epithelium is continuously affected by 
various extrinsic (e.g. bacteria and food antigens) and in-
trinsic factors (e.g. gastroesophageal acid reflux)  [1] . De-
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ferent parts of the gastrointestinal tract and during patho-
genic/inflammatory conditions. Moreover, changes in 
the mucus layer show dynamics due to mechanical and 
chemical erosions as one step in the dynamics of damage 
and restoration by continuous secretion from proper 
esophageal glands, the squamous epithelium itself, and 
swallowed saliva  [6] . Other defensive proteins secreted 
from the proper esophageal glands include bicarbonate, 
prostaglandin E 2 , epidermal growth factor, and trans-
forming growth factor-α. Secretion is stimulated by 
5HTR4  [7–9] . In addition, acid and pepsin can also in-
crease expression of esophageal mucins  [6, 10] .
 Mucins are protective glycoproteins that have O-
linked glycosylation and tandem repeat domains, and are 
also more or less resistant to action of proteases due to 
repeated sulfur bindings  [6] . These sulfur bindings can be 
broken by acetylcysteine which is also used pharmaceuti-
cally. Within the gastrointestinal tract, two major forms 
of mucins exist: (1) a membrane bound form and (2) a 
secreted form.
 Mucin secretion of the esophageal squamous epithe-
lium can be demonstrated by using a periodic acid-Schiff 
stain, which stains the esophageal mucins with a light-
blue color. In this context it was shown that mucin secre-
tion is decreased in erosive esophagitis and increased in a 
reversible fashion again with mild esophagitis and after 
curing esophagitis with complete mucosal healing, irre-
versibly  [10, 11] . It turned out that expression especially 
of Muc1 and Muc4 is decreased but Muc3 and Muc5AC 
glycoproteins are increased. It cannot be explained in de-
tail why individuals with endoscopic negative reflux dis-
ease have mucin expression levels like healthy controls. 
Either people believed to suffer from negative reflux dis-
ease suffer from nonreflux disease-related symptoms or 
those considered to represent a healthy control may par-
tially have refluxate in the esophagus but without any 
symptoms  [12] . Currently it is not clear how to solve this 
paradox. Compared to patients with Barrett’s esophagus 
(BE) with and without dysplasia, only a few conclusive 
studies are available on the esophageal squamous epithe-
lium. It is well documented how mucin expression chang-
es towards development of columnar metaplasia, dyspla-
sia, and adenocarcinoma  [6, 13–15] . In conclusion, ag-
gressive material in the esophagus, such as acid, stimulates 
the secretion of Muc5AC, Muc6, and Muc2 mainly from 
proper esophageal glands. If the compensatory mecha-
nisms are capable of providing intact epithelial protec-
tion, the individuals may never develop complications of 
gastroesophageal reflux disease such as BE. In BE the mu-
cin secretion differs from squamous epithelium, but even 
then if a different set of mucin may be capable to prevent 
malignant transformation, those individuals will present 
with BE, but not develop neoplasia. This concept is obvi-
ously true for the vast majority of individuals with BE 
presenting with a yearly conversion rate towards neopla-
sia of 0.12%  [16] .
 Second Line of Defense  –  The Multilayered 
Squamous Epithelium
 The second epithelial barrier is composed of the mul-
tilayered stratified nonkeratinized squamous epithelium 
composed of the stratum granulosum, stratum spinosum, 
and stratum germinativum (i.e. basal layer; fig. 2). The 
stratum granulosum is the most luminal layer and pro-
vides a permeability barrier  [17–20] . This permeability 
barrier is composed of cell membranes in combination 
with junctional complexes that prevent direct diffusion of 
 Table 1.  Summary of factors for esophageal defense
 1  Luminal acid clearance 
 2  Mucus layer 
 3  Multilayered squamous epithelium 
 4  Acid transport mechanisms 
 5  Continuous blood flow 
 6  Cytokine-transmitted regeneration processes 
 Fig. 1. Various expression patterns of desmosomal cadherins with-
in the esophageal squamous epithelium.
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luminal contents into the cells or the intercellular spaces. 
Cell membranes are hydrophobic; in combination with 
the sodium channels that are inhibited by luminal acid 
pH, no acidic material can diffuse into an intact cell mem-
brane. Junctional complexes between the cells are com-
posed of tight junctions, adherent junctions, and desmo-
somes composed of desmosomal cadherins with inter- 
and extracellular domains that limit the rate of ion 
diffusion through such complexes between the cells  [21, 
22] . Tight junctions are composed of occludins and clau-
dins (mainly claudin1 and claudin4)  [23, 24] . Adherent 
junctions mainly consist of E-cadherin  [25] . These com-
plexes seal intercellular spaces and connect cells ( fig. 1–3 ). 
Desmosomes within the squamous epithelium allow not 
 Fig. 2. Pathophysiology of gastroesopha-
geal reflux disease. First, the acid-pepsin at-
tacks the multilayered squamous esopha-
geal epithelium, weakening cell junctions. 
This leads to a widening of cell gaps thus 
allowing acid penetration into the lamina 
propria. 
 Fig. 3. Interaction of different desmogleins 
and plasma membrane. 
  Co
lo
r v
er
si
on
 a
va
ila
bl
e 
on
lin
e  
  Co
lo
r v
er
si
on
 a
va
ila
bl
e 
on
lin
e  
 Esophageal Resistance Dig Dis 2014;32:6–10
DOI: 10.1159/000357001
9
only the sealing and connecting of cells, but can also pro-
vide cellular, protein, or ion transport through intercel-
lular spaces  [26] .
 Third Line of Defense – Acid Transport
 In situations with luminal H+ excess with passive dif-
fusing into cells or metabolic intracellular H+ produc-
tion, ion transporters in the cell membrane are capable of 
removing excessive H+ from the cell, increasing the pH 
to a neutral level. Within the esophageal epithelium these 
transporters are located basolaterally and contain a sodi-
um-dependent, chloride-bicarbonate exchanger and a 
sodium-hydrogen ion exchanger of isotype 1  [21, 22] . In 
case intercellular pH needs to be decreased, another chan-
nel gets activated resulting in the transportation of H+ 
into the cell: the disulfonic stilbene-sensitive Na-inde-
pendent, chloride-bicarbonate exchanger  [27, 28] . Ac-
cordingly, when acid is recruited in the intercellular 
space, the previously mentioned chloride-bicarbonate 
exchanger operates to acidify the cell cytosol by exchang-
ing intracellular bicarbonate for extracellular chloride. In 
this context, it has been shown via in vitro experiments 
that pharmacological blockade of this exchanger can pre-
vent acid-induced cell necrosis of the esophageal epithe-
lium  [27, 28] .
 Other Factors Influencing Esophageal Epithelial 
Resistance
 Other factors that influence esophageal epithelial re-
sistance include continuous blood flow to supply cells 
with oxygen and nutrients to ensure the integrity of the 
epithelium. Cell restitution after injury can be achieved 
within 30–60 min due to migration of viable cells adjacent 
to the injury into the necrotic areas  [29–31] . Regenera-
tion is a much slower process that can take up to days or 
weeks because it depends on mitosis and synthesis of 
DNA and proteins. A major disadvantage of the regen-
eration process is that regeneration occurs from the basal 
cell layer, provoking the requirement of cells to migrate 
upwards to the necrotic area. Prolonged damage with re-
peated sequences of ongoing damage will disturb the bal-
ance between healing and damaging, thereby resulting in 
erosive or ulcerative esophagitis. Cell injury also attracts 
inflammatory infiltrates. Chemokines and cytokines re-
cruit immune cells by paracrine and systemic spread. An 
inflammatory reaction contributes to the clearance of de-
bris, but also damages the normal adjacent epithelium by 
toxic noxious agents like reactive oxygen and nitrogen 
species. In addition, it is known that esophageal inflam-
mation impairs lower esophageal sphincter pressure and 
contractility as well as delays acid clearance  [32] . Accord-
ingly, therapies aim to disrupt this vicious cycle by pro-
found acid suppression.
 Conclusion
 The esophageal epithelium is affected by various nox-
ious luminal agents, most notably acid and pepsin. Mul-
tiple esophageal defense mechanisms protect the esopha-
geal epithelium under normal circumstances from severe 
injury. In contrast, the absence of these defense mecha-
nisms leads to mucosal inflammation (e.g. erosive esoph-
agitis) and may predispose to other, noninflammatory 
conditions like BE and esophageal cancer. Successful pro-
tection mechanisms of the esophageal epithelium include 
(1) luminal acid clearance, (2) the mucus layer, (3) the 
multilayered squamous epithelium, (4) acid transport 
mechanisms, (5) continuous blood flow, and (6) various 
cytokine-transmitted regeneration processes. A balanced 
homeostasis between these protective factors is essential 
for a healthy environment. Nevertheless, the mechanisms 
finally leading to a decrease of esophageal defense remain 
poorly understood and need further investigation.
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